Scinai Immunotherapeutics Filing Relates to Offering of 7.6 Million ADSs
A SEC filing says the offering relates to 7.6 million ADSs representing 303.50 billion ordinary shares, sold by shareholders.
A SEC filing says the offering relates to 7.6 million ADSs representing 303.50 billion ordinary shares, sold by shareholders.